Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EMPAGLIFLOZIN Cause Urinary incontinence? 142 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 142 reports of Urinary incontinence have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 0.4% of all adverse event reports for EMPAGLIFLOZIN.

142
Reports of Urinary incontinence with EMPAGLIFLOZIN
0.4%
of all EMPAGLIFLOZIN reports
4
Deaths
35
Hospitalizations

How Dangerous Is Urinary incontinence From EMPAGLIFLOZIN?

Of the 142 reports, 4 (2.8%) resulted in death, 35 (24.6%) required hospitalization, and 7 (4.9%) were considered life-threatening.

Is Urinary incontinence Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 142 reports have been filed with the FAERS database.

What Other Side Effects Does EMPAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,644) Fungal infection (1,941) Blood glucose increased (1,797) Euglycaemic diabetic ketoacidosis (1,769) Weight decreased (1,661) Urinary tract infection (1,439) Ketoacidosis (1,411) Dizziness (1,372) Nausea (1,333) Vomiting (1,201)

What Other Drugs Cause Urinary incontinence?

MIRABEGRON (611) ADALIMUMAB (471) FINGOLIMOD (470) OCRELIZUMAB (431) RISPERIDONE (406) TERIFLUNOMIDE (365) DIMETHYL (355) ARIPIPRAZOLE (350) DALFAMPRIDINE (344) QUETIAPINE (336)

Which EMPAGLIFLOZIN Alternatives Have Lower Urinary incontinence Risk?

EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN EMPAGLIFLOZIN vs EMSAM EMPAGLIFLOZIN vs EMTRICITABINE

Related Pages

EMPAGLIFLOZIN Full Profile All Urinary incontinence Reports All Drugs Causing Urinary incontinence EMPAGLIFLOZIN Demographics